Research has found that CBD has many medical properties including:
Antiemetic - Reduces nausea and vomiting
Anticonvulsant - Suppresses seizure activity
Antipsychotic - Combats psychosis disorders
Anti-inflammatory - Combats inflammatory disorders
Antioxidant - Combats neurodegenerative disorders
Anti-tumoral/Anti-cancer - Combats tumor and cancer cells
Anxiolytic / Antidepressant - Combats anxiety and depression disorders
There has been a research on a wide array of different medical conditions which have shown that CBD has a high potential for medical treatment
Cigarette Addiction - 2013 - Study participants who were taking CBD saw a nearly 40 percent drop in their intake. (http://cannabisclinicians.org/wp-content/uploads/2013/07/CBDcigarettes.pdf)
Acne - 2014 - CBD can provide treatment for acne. (http://www.jci.org/articles/view/64628)
Fibromyalgia - 2011 - Participants that used CBD saw a reduction in their symptoms and pain. (https://www.ncbi.nlm.nih.gov/pubmed/21533029)
Post Traumatic Stress Disorder - 2014 - Those with PTSD are often overcome with anxiety and stress, so patients frequently find relief by using cannabidiol. (https://www.ncbi.nlm.nih.gov/pubmed/23829364)
Schizophrenia - 2014 - Amisulpride and CBD were compared between 42 schizophrenia patients. The two treatments were deemed effective, but the short side-effect profile of CBD out shined the pharmaceutical option. (https://www.ncbi.nlm.nih.gov/pubmed/24309088)
Arthritis - 2014 - Promising results that have been recently obtained in support of the therapeutic value of CBD for osteoarthritis management. (https://www.ncbi.nlm.nih.gov/pubmed/24494687)
Diabetes - 2008 - The endocannabinoid system participates in the control of lipid and glucose metabolism at several levels, with the possible endpoint of the accumulation of energy as fat If dysregulated it might contribute to excess visceral fat accumulation associated with obesity and type 2 diabetes. (https://www.ncbi.nlm.nih.gov/pubmed/18563385)
Alcoholism - 2015 - Cannabidiol (CBD) is thought to modulate various neuronal circuits involved in drug addiction. (https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4444130/pdf/sart-9-2015-033.pdf)
Multiple Sclerosis - 2005 - In some cases, the administration of CBD significantly reduced neuropathic pain, spasticity, muscle spasms and sleep disturbances. (https://www.ncbi.nlm.nih.gov/pubmed/16317825)
Chronic Pain - 2014 - CBD has been demonstrated to be effective in a range of neuropathic pain models, and there is mounting evidence for therapeutic use in human neuropathic pain conditions. (https://www.ncbi.nlm.nih.gov/pubmed/25160710)
Depression - 2014 - CBD has a great psychiatric potential, including uses as an antidepressant-like and anxiolytic-like compound. (https://www.ncbi.nlm.nih.gov/pubmed/24923339)
Antibiotic - Resistant Infections - 1976 - The minimum inhibiting concentrations of CBD for staphylococci and streptococci in between 1-5 mµ/ml. (https://www.ncbi.nlm.nih.gov/pubmed/1085130)
Epilepsy - 2014 - The scientific data support the role of the endocannabinoid system in seizure generation, maintenance, and control in animal models of epilepsy. (https://www.ncbi.nlm.nih.gov/pubmed/25282526)